Merck (MRK) Tops Q2 EPS by 2c; Updates FY16 EPS Outlook
Tweet
Share
E-mail
Get Alerts MRK Hot Sheet
Price: $125.99 -2.23%
EPS Growth %: -16.9%
Financial Fact:
Less: Net Income Attributable to Noncontrolling Interests: 122.8M
Today's EPS Names:
CRMT, PKE, HELE, More
EPS Growth %: -16.9%
Financial Fact:
Less: Net Income Attributable to Noncontrolling Interests: 122.8M
Today's EPS Names:
CRMT, PKE, HELE, More
Join SI Premium – FREE
Merck (NYSE: MRK) reported Q2 EPS of $0.93, $0.02 better than the analyst estimate of $0.91. Revenue for the quarter came in at $9.84 billion versus the consensus estimate of $9.78 billion.
GUIDANCE:
Merck sees FY2016 EPS of $3.67-$3.77, versus the consensus of $3.72.
For earnings history and earnings-related data on Merck (MRK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AZZ, Inc. (AZZ) Tops Q1 EPS by 16c, Offers Guidance
- Dollar Tree upgraded on earnings upside potential despite ongoing traffic woes
- EMD Serono Announces FDA Breakthrough Therapy Designation for Enpatoran in Lupus Patients with Active Skin Manifestations
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
